| Literature DB >> 27341433 |
Jenny L Valentine1, Linxiao Chen1, Emily C Perregaux2, Kevin B Weyant1, Joseph A Rosenthal3, Christian Heiss4, Parastoo Azadi4, Adam C Fisher5, David Putnam6, Gregory R Moe7, Judith H Merritt5, Matthew P DeLisa8.
Abstract
The development of antibodies against specific glycan epitopes poses a significant challenge due to difficulties obtaining desired glycans at sufficient quantity and purity, and the fact that glycans are usually weakly immunogenic. To address this challenge, we leveraged the potent immunostimulatory activity of bacterial outer membrane vesicles (OMVs) to deliver designer glycan epitopes to the immune system. This approach involved heterologous expression of two clinically important glycans, namely polysialic acid (PSA) and Thomsen-Friedenreich antigen (T antigen) in hypervesiculating strains of non-pathogenic Escherichia coli. The resulting glycOMVs displayed structural mimics of PSA or T antigen on their surfaces, and induced high titers of glycan-specific IgG antibodies following immunization in mice. In the case of PSA glycOMVs, serum antibodies potently killed Neisseria meningitidis serogroup B (MenB), whose outer capsule is PSA, in a serum bactericidal assay. These findings demonstrate the potential of glycOMVs for inducing class-switched, humoral immune responses against glycan antigens.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27341433 PMCID: PMC5116915 DOI: 10.1016/j.chembiol.2016.05.014
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116